Tracking babies born to moms on heart drug
NCT ID NCT05939700
Summary
This study aims to understand the safety of the heart medication mavacamten during pregnancy and breastfeeding. Researchers will follow about 20 people who took the drug while pregnant or nursing, tracking the health of both the parent and baby for up to a year after birth. This is an observational study, meaning participants are not given any new treatment; the goal is to gather safety information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREASTFEEDING are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Locations
-
The Mavacamten Pregnancy Surveillance Program, PPD Inc
RECRUITINGWilmington, North Carolina, 28401-3331, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.